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Constitution of the Board
The General Medical Services (Payments) Board is a body corporate with perpetual succession and a
common seal constituted by Order of the Minister for Health under Section 11 of the Health Act, 1970.
The Board consists of fourteen members comprising:
(a) (i) one officer of each Health Board designated by the Chief Executive Officer of the Health Board and
(ii) one officer of each Area Health Board established by Section 14 of the Eastern Regional Health
Authority Act, 1999, designated by the Area Chief Executive of the Area Health Board and 
(b) three other persons appointed by the members referred to in (a) (i) and (ii).
Functions of the Board
It is the duty of the Board to perform on behalf of the Health Boards the following functions in relation
to the provision of services by General Practitioners, Pharmacists, Dentists and Optometrists/
Ophthalmologists under Sections 58, 59 and 67 (i) of the Health Act 1970:
(a) the calculation of payments to be made for such services;
(b) the making of such payments;
(c) the verification of the accuracy and reasonableness of claims in relation to such services; 
(d) the compilation of statistics and other information in relation to such services.
Ms. M.Windle Mr. S. Mannion Mr. P. Burke
Ms. B. Hyland Mr.T. Hourigan Mr. R. Dooley Mr. P. Healy Ms. B. Kiberd
Mr. D. Moloney Mr. H. Kane Ms. M. O’Connell Mr.T. McGuinnMr. P. O’Dowd Mr. G. Day
Mr. C. Desmond
6 General Medical Services Report 2004
Almost all payments for services provided in the
community by General Practitioners, Community
Pharmacies, Dentists and Optometrists/
Ophthalmologists are made by the Board.
Payments in the Year 2004 were in excess of
€1.65bn. Estimated payments by the Board for
2005 are €1.97bn.
Claim data is processed and payments are made by
the Board under the following Schemes/Payment
Arrangements:
General Medical Services (GMS)
Persons who are unable without undue hardship
to arrange general practitioner medical and
surgical services for themselves and their
dependants and all persons aged 70 years and over
receive a free general medical service.
Drugs, medicines and appliances supplied under
the Scheme are provided through retail
pharmacies. In most cases the Doctor gives a
completed prescription form to a person, who
takes it to any pharmacy that has an agreement
with a Health Board to dispense GMS
prescription forms. In rural areas the Doctor may
dispense for those persons who opt to have their
medicines dispensed by him/her. All GMS claims
are processed and paid by the Board. 
Drugs Payment Scheme (DPS)
Under the Drugs Payment Scheme persons who
are ordinarily resident in the State and who do not
have a current medical card can benefit - an
individual or family has now to pay no more than
€78 in a calendar month for approved drugs,
medicines and appliances for themselves or their
families. In order to benefit under this Scheme a
person must register themselves and their
dependants with their local Health Board. Items
currently reimbursable under the Drugs Payment
Scheme are those listed in the GMS Code Book.
Other items which were reimbursable under the
DCS and Refund of Drugs Schemes continue, in
certain circumstances, to be reimbursable under
the Drugs Payment Scheme. DPS claims are
processed and paid by the Board. 
Long Term Illness Scheme (LTI)
On approval by Health Boards persons who suffer
from one or more of a schedule of illnesses are
entitled to obtain, without charge, irrespective of
income, necessary drugs/medicines and/or
appliances under the LTI Scheme. All LTI claims
are processed and paid by the Board. 
Dental Treatment Services Scheme (DTSS)
Under the Dental Treatment Services Scheme
GMS eligible adults have access to a range of
treatments and clinical procedures comprised of
Routine Treatments and Full Upper and Lower
Dentures. Routine Treatments are now available
for all eligible persons. Dentists may also
prescribe a range of medicines to eligible persons.
All claims under the DTSS are processed and paid
by the Board. 
European Economic Area (EEA) and
Switzerland
Following European Union (EU) enlargement
and a separate agreement with the Swiss
Confederation, the European Health Insurance
Card (EHIC) was introduced with effect from
June 2004. 
On production of an EHIC, residents of an
EU/EEA country or Switzerland can get
necessary healthcare in the public system or any
other one of those countries, if they become ill or
injured while on a temporary stay in that country.
The EHIC replaced the older forms to obtain
such treatment (such as the E111 or the E128),
which were in use until May 2004. One EHIC is
needed for each individual or family member. The
EHIC does not cover a temporary stay where the
intention of the visit is seeking healthcare per se.
In accordance with reciprocal arrangements with
the United Kingdom, an EHIC is not required for
UK residents to get necessary healthcare while on
Community Based Services – Payment Arrangements 
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a temporary visit to the Republic of Ireland. It is
sufficient to show proof that one is ordinarily
resident in the UK - in practice this means a
driving licence, passport or similar document. 
The service may be accessed from General
Practitioners and Community Pharmacists who
have a service contract under the GMS Scheme. A
General Practitioner may issue a prescription on a
GMS prescription form to a person with
established eligibility. 
The GMS (Payments) Board pays for general
practitioner and pharmaceutical services and for
medication and appliances in respect of visitors to
Ireland from the relevant countries. 
High Tech Drugs (HTD)
Arrangements are in place for the supply and
dispensing of High Tech medicines through
Community Pharmacies. Such medicines are
generally only prescribed or initiated in hospital
and would include items such as anti-rejection
drugs for transplant patients or medicines used in
conjunction with chemotherapy or growth
hormones. The medicines are purchased by the
Health Boards and supplied through Community
Pharmacies for which Pharmacists are paid a
patient care fee: the cost of the medicines and
patient care fees are paid by the Board. 
Primary Childhood Immunisation Scheme
A National Primary Childhood Immunisation
Scheme provides for immunisation of the total
child population with the aim of eliminating, as
far as possible, such conditions as Diphtheria,
Polio, Measles, Mumps, Rubella and more
recently Meningococcal C Meningitis. Payments
under this Scheme to Doctors in the Midland,
Mid-Western, Southern and Western Health
Boards are made by the Board. 
Health (Amendment) Act 1996
Under the Health (Amendment) Act 1996 certain
health services are made available without charge
to persons who have contracted Hepatitis C
directly or indirectly from the use of Human
Immunoglobulin - Anti D or the receipt within
the State of another blood product or blood
transfusion. General Practitioner services,
pharmaceutical services, dental services and
optometric/ophthalmic services provided under
the Act are paid for by the Board.
Methadone Treatment Scheme
Methadone is prescribed and dispensed by Doctors
and Pharmacists for approved clients under the
Methadone Treatment Scheme - capitation fees
payable to participating Doctors and Community
Pharmacists and claims by pharmacies for the
ingredient cost of the Methadone dispensed and
the associated dispensing fees are processed and
paid by the Board.
Health Board Community Ophthalmic
Services Scheme (HBCOSS)
Under the Health Board Community Ophthalmic
Services Scheme, adult medical card holders 
and their dependants are entitled, free of 
charge, to eye examinations and necessary
spectacles/appliances. Claims by Optometrists/
Ophthalmologists are paid by the Board. Claims
for spectacles provided under the Children’s
Scheme are also paid by the Board.
Immunisations for certain GMS 
Eligible Persons
Agreement was reached between the Department
of Health & Children and the Irish Medical
Organisation on fee rates to be applied to certain
immunisations for GMS eligible persons. The
immunisations encompassed by the agreement
are:- Pneumococcal, Influenza, Hepatitis B and
the combined Pneumococcal/Influenza. The
Board facilitated claiming for any of these
immunisations by extending the range of codes for
‘Special Items of Service’.
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This year, my third and final year as Chairman of the
General Medical Services (Payments) Board, is a
landmark year in the Irish Health Service and for the
GMS (Payments) Board, as we move forward into
the new era of health service reform set out by
Government in June 2003. It is my pleasure to join
with the members of the Board to present the
Annual Report for the year 2004, the Board’s 31st
and last Annual Report. 
As this is the last year of tenure for the Board of the
GMS (Payments) Board I would like to thank all of
the Board Members, Chairpersons and Executive
past and present, for their dedication and work over
the years in playing a major role in the delivery,
development and operation of primary care
reimbursement over the last 32 years. I would like to
express a particular word of gratitude to the
outgoing Board Members for their commitment and
hard work during this challenging and transition
year. My thanks to them for their dedication and
collegiality not just as members of the GMS
(Payments) Board, but also as members of the
various Board Sub Committees. 
The Health Service Reform Programme sets out
details for unprecedented change and reform in the
health system with the Local, Regional and National
structures of the new Health Service Executive
(HSE) coming into effect on 1st January 2005. As
the single largest reform project undertaken in the
State this programme provides us all with an
unparalleled opportunity to modernise and to
improve service provision to all of our clients,
stakeholders and partners, in a cohesive and
challenging way, through modernising the
mechanisms, technologies and communication
structures and realising the benefits that can be
achieved through economies of scale.
Under the Reform Programme the GMS
(Payments) Board will form part of the Health
Service Executive and will be under the National
Shared Services Directorate. It is now the Primary
Care Reimbursement Service (PCRS). The National
Director for Shared Services, Ms. Laverne
McGuinness, will take this function forward as a part
of National Shared Services. I take this opportunity
to also wish her, and all the staff in the Health
Service Executive, well with the challenges ahead.
Moving forward it is planned that all of the valuable
information, which year on year has been presented
by the GMS (Payments) Board, will continue to be
made available to the public by National Shared
Services. This valuable set of data will be made
available for information and as assistance to those
who require it for use for research purposes.
The establishment of National Shared Services as
the third pillar, along with National Hospitals
Office, National Primary, Community &
Continuing Care, in the newly formed National
Health Structure, was a decision of the Government
under the reform programme.
The main principles, which underpinned the move
towards establishing National Shared Services, were
articulated in the Prospectus Report:
■ Elimination of duplicate activities across
different organisations, functions and processes;
■ Creation of economies of scale;
■ Greater leveraging of technology, management
and specialist resources;
■ Standardisation of processes, practices and the
application of leading practice to improve the
quality and overall consistency of services
provided. 
The National Shared Services, when fully
implemented, will deliver the following services on a
national basis for the unitary Health Service
Executive:
■ Finance;
■ Procurement;
■ Human Resources;
■ Information Communication Technology;
■ Primary Care Reimbursement.
Chairman’s Statement
Ms. M. Windle (Chairman)
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The National Shared Services Primary Care
Reimbursement Service will continue to perform the
following functions in relation to the provision of
services by Primary Care Contractors i.e. General
Practitioners, Pharmacists, Dentists and Optometrists/
Ophthalmologists:
■ The calculation of payments to be made to Primary
Care Contractors for services rendered in the
community under contract;
■ The verification of the accuracy and reasonableness
of claims in relation to such services;
■ The making of such payments;
■ The compilation of statistics and other information
in relation to such services and the communication
of such information to persons concerned with the
operation of such services.
The National Shared Services Primary Care
Reimbursement Service is the largest central service
provider in the health sector, with millions of
transactions successfully delivered each year (54 million
in 2004). The Primary Care Reimbursement Service will
play a major role in the development of the National
Shared Services, leveraging both its experience and
expertise in shared service provision and its extensive
investments in a national Information Communication
Technology (ICT) infrastructure. 
In relation to 2004 the total expenditure arising on the
Schemes administered by this service was €1.65billion
and will grow to an estimated €1.97billion in 2005.
Expenditure has more than doubled over the past five
years. At current levels this accounts for approximately
18% of total non-capital public health expenditure. This
underlines the significance of this function within the
public health service and given its scale, emphasises the
requirement for robust systems and governance/
accountability structures to be in place. 
The core business of the National Shared Services
Primary Care Reimbursement Service will be the
processing of claims from Primary Care Contractors, the
making of related payments and the provision of
information to the contractors, the Department of
Health & Children and Health Agencies. We have made
major strides in the last year in a range of critical areas
including using our valuable information database to
improve and support our planning and monitoring
functions, strengthen our governance and accountability
arrangements, work on the implementation of an
eCommerce infrastructure and also in improving the
efficiency of our day-to-day business operations. Many
other projects were undertaken or continued throughout
2004. 
This Annual Report for 2004 reflects, as in previous
years, the many and varied Schemes and payment
systems which generated the workload of the GMS
(Payments) Board in the year under review. 
As in previous years, the executive continued to work
closely with all of our stakeholders and partners to
discuss and work through issues of mutual interest and
where necessary to endeavour to resolve difficulties when
they arise. The co-operation and goodwill shown by
these groups is very much appreciated. 
We would like to acknowledge the General Practitioners,
Community Pharmacists, Dentists, Optometrists/
Ophthalmologists and their staff for their continued
dedication and leadership in providing Primary Health
Care Services to their communities. We recognise the
importance of good communication with our
partners/customers and we will continue to deliver new
services to provide improved information and support to
our entire client base. 
The staff of the Health Agencies, especially those who
deal directly with service providers and service users and
who interface regularly with us, are again very deserving
of a special word of appreciation. 
My thanks also to the Head of Primary Care
Reimbursement Service, Mr. Patrick Burke, the
management and staff for their dedication,
professionalism, loyalty and achievements during the
year. We have a team of dependable, highly motivated
and respected staff who continue to respond to new
challenges with determination and who are committed to
providing the best possible service to our clients.
I also wish to thank the Tánaiste and Minister for Health
& Children, the Secretary General of the Department
and his officials, for their continuing assistance and
support throughout 2004.
Finally as we hand over the GMS (Payments) Board to
the new Health Service Executive in January 2005 I wish
it continued success and I know that the valuable work
and achievements of the organisation will continue and
develop under the National Shared Services Directorate.
Maureen Windle
Chairman
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The GMS (Payments) Board validates claims,
administers the payments and compiles relevant
statistics in relation to the community based
services provided by 5,372 primary care
professionals on behalf of the Health Boards. The
Board administers these payments in relation to a
range of Schemes relating to the treatment of
eligible persons in a primary or community care
setting and covers, among other things, payments
in respect of medical card, drug cost subsidisation,
long term illness, high tech drugs, dental
treatment and ophthalmic services.
The Schemes administered include: 
● General Medical Services (GMS)
● Drugs Payment (DP)
● Long Term Illness (LTI)
● Dental Treatment Services (DTS)
● European Economic Area (EEA)
● High Tech Drugs (HTD)
● Primary Childhood Immunisation 
● Health (Amendment) Act, 1996
● Methadone Treatment 
● Health Board Community Ophthalmic
Services (HBCOS)
The Schemes are at the centre of the primary care
infrastructure in the health system and a major
part of total expenditure within the Schemes is
demand led. The population eligible for services
under the Schemes also significantly influences
this expenditure. Expenditure by the Board has
more than doubled over the past five years and at
current levels accounts for nearly 18% of total
non-capital public health spending. 
The total expenditure arising from the Schemes
administered by the Board in 2004 was €1.65bn
and is expected to increase to approximately
€1.97bn in 2005. This increase is due to a number
of factors – higher population coverage, expansion
of services provided within existing Schemes,
increased fee rates to contractors, provision and
reimbursement of more expensive drugs/
medicines and inflationary cost factors. 
Payments in the year 2004 were in excess of
€1.65bn, significantly up (15.4%) on payments of
€1.43bn made in the year 2003.
The following table sets out in summary form the
overall increase in terms of the number of items
that the Board reimbursed during 2004 and 2003,
and the associated costs.
Summary of trends and patterns - 
2004 over 2003 
%
Description 2004 2003 Change
Persons Registered 2.71m 2.65m 2.26%
% of registered 
medical card 
population who 
availed of services 96% 94% -
No. of transactions 54m 48m 12.5%
Payments
Doctors €317.50m €295.74m 7.36%
Pharmacies €1,092.70m €943.21m 15.85%
Dentists €52.49m €49.87m 5.25%
Optometrists €17.44m €13.75m 26.84%
Wholesalers (HTD) €141.41m €103.58m 36.52%
Estimated payments by the Board for 2005, based
on the information currently available, will be
approximately €1.97bn. 
The Board prepares a three year projection of
Scheme Expenditures to enable an informed view
to be made of known trends over the medium
term. Such an exercise is invaluable in assessing
the potential impact of an ageing population on
the cost of the GMS Scheme, following its
Review and Outlook
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extension to all persons aged 70 years and over,
the impact of increased prescribing rates and
other similar issues. 
Health Reform Programme
In 2003 the Government published its plans for
the reform of the health service, together with the
three reports (‘Prospectus’, ‘Brennan’ and
‘Hanly’) which underpinned the various
proposals for change. The Health Service
Reform Programme sets out details for
unprecedented change and reform in the health
system with the Local, Regional and National
structures of the new Health Service Executive
(HSE) coming into effect on 1st January 2005. 
The Reform Programme outlines the shape of
the proposed new structures including - a Health
Service Executive, a number of Regional Offices,
National Hospitals Office, National Primary,
Community & Continuing Care and National
Shared Services. As the largest shared service
currently operating within the health sector and
the only agency providing such services on a
national basis, National Shared Services will be in
a position to leverage the extensive investments in
modern IT systems and infrastructure that the
Board has made in recent years to enhance
communications with Health Agencies and
Primary Care. 
The GMS (Payments) Board looks forward to
continuing to work with colleagues from
throughout the Health Areas to establish the
National Shared Services during 2005, leading to
a rapid and successful transition to the new
structures and processes.
Primary Care Contractors – Claims and
Payments.
At year-end 84% of Pharmacists were submitting
approximately 3.1m claim items electronically
each month and in the majority of cases were
qualifying for payment within 14 working days. 
The Comptroller and Auditor General
(Amendment) Act, 1993 provides for Audit by the
Office of the Comptroller and Auditor General.
Over the past number of years the Audit has
highlighted uncertainty regarding the validity of
a proportion of claims submitted for payment.
The volume of pharmacy claims, which are
presented for payment with incomplete patient
data, has been a matter of serious concern to the
Board over many years. 
In 2003, the Board took appropriate action
following the advice from the Department of
Health & Children to the effect that the
Government had decided that the practice of
reimbursing Pharmacists for claims with
incomplete eligibility documentation should
cease.
The Board has worked with the Irish
Pharmaceutical Union (IPU) and other
stakeholders to jointly implement initiatives
aimed at resolving the issues underpinning these
incomplete claims, and the Government decision
in relation to DPS claims was implemented in
2004. The Board continues to work with the
main stakeholders to continue to implement the
Government decision in relation to all Schemes.
In the course of the year the Board met with
representatives of the Irish Medical Organisation
(IMO) on a number of occasions to discuss
operational issues. These meetings provided a
forum for discussion regarding how the operation
of the Schemes could become more transparent
and effective.
It was agreed that through the use of technology
General Practitioners could be afforded greater
access to the Board’s databases and that the
current reporting arrangements could be
enhanced to provide greater clarity and
transparency.
It was also agreed that this forum would examine
how the current business processes regarding
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client registration could be streamlined and how
the proposed implementation of an electronic
swipe card, with more comprehensive client and
contractor data, could assist in this regard.
The Board is consequently participating in the
GP Messaging Project, alongside colleagues from
the Health Boards and the voluntary sector, to
develop message protocols and associated
infrastructure to support improved
communications with General Practice.
At year-end more than 300 General Practitioners
have available to them a facility for inputting
Special Type Consultation/Special Service claims
directly into the Board’s claims processing
systems using a web based system developed and
implemented by the Board in 2002. This web
based facility has also been enhanced to allow
General Practitioners to access the lists of
patients on their panels and download these lists
to input into their own local Practice
Management Systems. We are aware of the
potential and opportunities that can be exploited
through these media and will continue to support
the development of health care applications
conscious of the requirement for security, privacy,
data protection issues and confidentiality.
Administration
In 2004, General Administration costs in the
GMS (Payments) Board were €15.5m. 
Of this the principal cost headings were – 
● €0.78m was the cost of providing laminated
plastic cards for the Drugs Payment
Scheme, which was introduced in July 1999 
● €2.72m was attributable to ongoing
computer systems development,
maintenance and software licence costs
● €0.44m was expended on claim stationery
(prescription forms, claim forms etc.) 
● €1.64m for other stationery supplies 
● €1.02m was expended on postal and
telephone charges
● Salaries, wages and other staff costs totalled
€5.37m i.e. 0.32% of the Board’s total
expenditure. 
Information Technology and Business
Strategy Development
Over recent years the Board has built a major IT
infrastructure for supporting its business and
communications with stakeholders, including the
Health Boards and the Primary Care
Contractors.
This infrastructure comprises -
● Major new and enhanced national systems
for client identity and eligibility validations
and Primary Care Contractors claims
validation and payment
● A wide-area network (WAN) connecting
pharmacies to the Board
● Encryption of all communications that
contain personal medical data between the
Board and external bodies
● Mutual authentication between the Board
and outside organisations
● System resilience and disaster recovery
features
The Board’s systems & infrastructure presents an
opportunity for the new Health Services
Executive to leverage major savings from the
current structures by dealing with all clients
across all Schemes in a single environment using
a single national Information Technology system
and infrastructure.
Review and Outlook continued
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Prompt Payment of Accounts Act
The policy of the Board is to comply with the
provisions of the European Communities (Late
Payments in Commercial Transactions)
Regulations, 2002 and the earlier Irish
enactment, the Prompt Payment of Accounts Act,
1997. The Board’s standard term of credit taken,
unless otherwise specified in specific contractual
arrangements, is 30 days. Appropriate internal
financial controls are in place, including clearly
defined roles and responsibilities and monthly
reporting and review of payment practices. 
Office Accommodation
Over the past 32 years the GMS (Payments)
Board’s business and associated IT infrastructures
have grown significantly, and will continue to
grow into the future. In order to ensure that a
proper business continuation strategy is in place,
the Board examined all aspects of its office
accommodation, including the IT facility and off-
site storage space. Following an evaluation of all
available options during 2002 and 2003 the Board
made a decision in 2004 to relocate to new
premises on the North Road, Finglas. Work is
underway to finalise arrangements and it is
anticipated that the Board will move to the new
premises towards the end of 2005. 
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● Payments in the Year were in excess of €1,652.83m.
● Claim data is processed and payments are made by the Board under the following Schemes:
■ General Medical Services (GMS);
■ Drugs Payment (DP); 
■ Long Term Illness (LTI);
■ Dental Treatment Services (DTS);
■ European Economic Area (EEA);
■ High Tech Drugs (HTD);
■ Primary Childhood Immunisation;
■ Health (Amendment) Act 1996;
■ Methadone Treatment;
■ Health Board Community Ophthalmic Services (HBCOS).
● At year end there were more than 2.71m persons registered as being eligible to benefit under the
General Medical Services, Drugs Payment, Long Term Illness, Dental Treatment and Health
Board Community Ophthalmic Services Schemes.
● More than 96% of eligible GMS persons availed of GP, Pharmaceutical, Dental or Ophthalmic
services provided by more than 5,372 Doctors, Pharmacists, Dentists and
Optometrists/Ophthalmologists.
● More than 47.2m prescription items were paid for by the Board - an increase of over 3.7m items
on 2003.
● Fees and allowances paid to Doctors totalled €317.5m.
● Payments to Pharmacies totalled €1,092.7m;
■ GMS €763.32m;
■ DP €226.83m;
■ LTI €85.55m;
■ EEA €1.8m;
■ Patient Care Fees under the HTD Scheme €6.8m;
■ The Health (Amendment) Act 1996, Methadone Treatment Scheme and DTS prescriptions
€8.4m.
● Payments to Dentists under the DTS totalled €52.49m.
● Payments to Optometrists/Ophthalmologists under the HBCOS totalled €17.44m.
● Payments to Wholesalers under the HTD Scheme totalled €141.41m.
● Administration costs in the accounting period of 2004 were €15.5m.
● Claims processed are in respect of services provided in the community and availed of by almost 51%
of the population.
Summary Statement of Activity During the Year 
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The Year 2004
Doctors Fees €220.91m
Allowances €96.59m
Pharmacists Fees and Mark-Up €272.34m
Drugs and Medicines €813.56m
Dentists €52.49m
High Tech Drugs Scheme 
Payment to Wholesalers €141.41m 
Patient Care Fees paid to Pharmacists €6.8m
Optometrists €17.44m
Administration €15.50m
Investment in General 
Practice Development €15.79m
Total of Payments for the year
€1,652.83m
● Fees to Doctors include an amount of €3.92m in respect of the Primary Childhood Immunisation
Scheme, €0.22m in respect of the Health (Amendment) Act 1996, €5.4m in respect of the
Methadone Treatment Scheme.
● Allowances paid to Doctors include an amount of €5.78m paid as superannuation to Retired District
Medical Officers and their dependants.
● Payments to Pharmacists include an amount of €1.36m in respect of drugs/medicines dispensed
under the Health (Amendment) Act 1996, an amount of €6.5m in respect of the cost of Methadone
dispensed under the Methadone Treatment Scheme and an amount of €0.52m in respect of DTS
prescriptions.
● Payments to Dentists include an amount of €55,587 in respect of treatments under the Health
(Amendment) Act 1996.
● Payments to Optometrists include an amount of €37,232 in respect of treatments under the Health
(Amendment) Act 1996.
● The corresponding figures for 2003 are – 
Total of Payments €1,431.78m.
Doctors’ Fees €207.85m and Doctors’ Allowances €87.89m.
Pharmacists’ Fees and Mark-Up €231.24m, Drugs and Medicines €706.41m.
Payments to Dentists under the DTS Scheme were €49.87m.
Payments to Optometrists €13.75m.
Investment in General Practice Development was €13.13m.
High Tech Drugs Scheme – Payment to Wholesalers €103.58m, Patient Care Fees €5.56m.
Administration €12.50m.
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2,210 Doctors 1,340 Dentists 489 Optometrists1,333 Pharmacists
Number of Agreements
The number of agreements between Health Boards and General Practitioners for the provision of
services to GMS persons reflects the policy position agreed between the Department of Health &
Children and the Irish Medical Organisation on entry to the GMS. In December 2004 there were
2,210 such agreements.
Number of Agreements as at 31st December 2004
Health Board Doctors Pharmacists Dentists Optometrists
East Coast Area 209 114 99 44 
South West Area 300 185 179 74
Northern Area 240 153 147 43
Midland 123 75 77 40
Mid-Western 204 126 100 38
North Eastern 163 115 123 50
North Western 131 75 60 24
South Eastern 212 144 122 49
Southern 372 211 290 71
Western 256 135 143 56
National *2,210 #1,333 +1,340 489
Corresponding Figures for 2003 2,181 1,292 1,340 463
* 226 GPs who do not hold GMS agreements and who were registered as providing services under the Primary Childhood Immunisation
Scheme, the Health (Amendment) Act 1996, Heartwatch and the Methadone Treatment Scheme at year end are included above.
# 11 Pharmacies who do not hold GMS agreements and who were registered as providing services under non GMS schemes at year end are
included above.
+ 184 Dentists who are employees of Health Boards and who provide services under the Dental Treatment Services Scheme are included above.
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Persons Eligible for Services
Eastern Regional Boards 339,079 493,674 49,598
Midland 69,615 87,640 4,996
Mid-Western 99,578 146,960 6,581
North Eastern 100,345 137,248 7,188
North Western 97,741 68,618 5,077
South Eastern 136,519 151,732 9,182
Southern 171,879 247,555 6,749
Western 134,158 135,824 4,133
National 1,148,914 1,469,251 93,504
% of Population 28.41% 36.33% 2.31%
Corresponding Figures for 2003 1,158,143 1,396,813 97,184
Health Board GMS DP LTI
GMS 1,148,914 LTI 93,504
Persons who are unable without undue hardship to arrange General Practitioner medical and surgical
services plus dental and optometric services for themselves and their dependants are provided with
such services free of charge under the GMS Scheme. An eligible person is entitled to select a Doctor
of his/her choice, from among those Doctors who have entered into agreements with Health Boards.
Drugs, medicines and appliances prescribed by participating Doctors for their GMS patients are
provided through Community Pharmacies. Dental and ophthalmic services are provided by Dentists
and Optometrists/Ophthalmologists who have contracted with Health Boards. GMS prescription
forms may be dispensed in any Pharmacy that has an agreement with a Health Board to dispense
GMS prescription forms. In rural areas, where a Doctor has a centre of practice three miles or more
from the nearest retail Pharmacy participating in the Scheme, the Doctor dispenses for those persons
served from the centre who opt to have their medicines dispensed by him/her. The number of eligible
GMS persons at year end included 54,338 persons who were entitled and had opted to have their
medicines dispensed by their GPs.
Under the terms of the Drugs Payment Scheme persons who do not have a medical card may apply
for a Drugs Payment Scheme card on an individual or on a family unit basis. Prescribed medicines,
which are reimbursable under the GMS, costing in excess of a specified amount per month, currently
€78 per family, is claimed by the Pharmacy and is paid by the Board.
On approval by Health Boards persons who suffer from one or more of a schedule of illnesses are
entitled to obtain, without charge, irrespective of income, necessary drugs/medicines and/or
appliances under the LTI Scheme. The Board makes payments on behalf of Health Boards for LTI
claims submitted by Pharmacies.
GMS - General Medical Services Scheme. DP - Drugs Payment Scheme. LTI - Long Term Illness Scheme.
Number of Eligible Persons as at 31st December 2004
DP 1,469,251 
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Payments to General Practitioners are categorised as fees and/or allowances. For the majority of GPs
who operate under the 1989 agreement the principle fee is the capitation per person which is weighted
for gender, age and distance from Doctor’s centre of practice - capitation fees totalled €157,367,358 in
2004 – an increase of €14,228,995 over 2003. Fees totalling €1,210,542 were paid to 17 GPs who
continue to provide services under the Fee-Per-Item of service agreements.
Apart from ‘Out-of-Hours’ fees and fees for a range of special services the cost of services provided in
normal hours by GPs for GMS persons, including the prescribing of necessary medicines, is
encompassed by the capitation fee. All GMS persons can avail of full GP services and in many cases they
can benefit from specialist clinics provided by GPs for issues such as Women’s Health, Family Planning
and Asthma.
In addition to a capitation fee an outside normal hours fee is payable for non routine consultations when
an eligible GMS person is seen by their GP or another GP acting on his/her behalf from 5pm in the
evening to 9am on the following morning (Monday to Friday) and all hours on Saturdays, Sundays and
Bank Holidays. The number of ‘Out-of-Hours’ claims increased to 547,001 in 2004 compared with
507,700 in 2003 - and the cost of such claims increased to €24,354,181 from €22,247,074 in 2003.
Special fees are payable for a range of 18 services such as excisions, suturing, vaccinations,
catheterization, family planning etc. (refer to page 32 for full list of special items) - the most frequent
claimed special service in 2004 was Influenza Vaccination (304,376) followed by Excisions (64,032) and
E.C.G treatments (45,943) - there was a total of more than 532,803 special services provided in 2004 -
special fees totalling €16,119,775 were paid in 2004.
Annual and Study Leave together with locum, nursing and secretarial support plus other practice
support payments account for most of the €96,591,919 allowances paid in the year. The total paid in
2003 was €87,886,787.
The total of payments to Doctors includes payments of: €3,923,476 under the Primary Childhood Immunisation Scheme; €215,031
to Doctors who provided services under the Health (Amendment) Act 1996; Heartwatch €1,665,800;Trainers/Trainee Grants
€1,656,627 and €5,444,813 under the Methadone Treatment Scheme.
For details of Fees and Allowances payable refer to pages 32 to 33.
Health Board 2004
Total of Payments to Doctors by Health Board
East Coast Area €22,908,827
South West Area €37,330,814
Northern Area €31,563,778
Midland €19,938,678
Mid-Western €26,976,563
North Eastern €28,350,471
North Western €24,596,738
South Eastern €37,173,563
Southern €50,055,124
Western €38,604,842
National €317,499,398
Corresponding Figure for 2003 €295,741,062
Payments to Doctors
Fees €220.91m Allowances €96.59m
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Corresponding 
figures for 2003 117,914 175,691 512,345 507,700
Health Board Fee-Per-Item Special Type Special Service Out-of-Hours
East Coast Area - 7,888 33,049 23,598
South West Area 23,673 17,239 54,051 50,956
Northern Area 25,157 12,771 45,052 43,001
Midland - 19,173 33,880 35,479
Mid-Western 9,743 19,000 44,391 41,192
North Eastern - 9,107 40,794 10,227
North Western - 13,032 47,532 44,955
South Eastern 9,776 16,628 72,320 75,595
Southern 34,113 40,916 86,045 131,715
Western - 30,706 75,689 90,283
National 102,462 186,460 532,803 547,001
A majority of Doctors are paid an annual capitation fee for each eligible person - the rate of payment is
determined by the age/gender of the person and distance between each person’s residence and the centre
of practice of their Doctor-of-Choice.
A minority of Doctors (17) who have continued to provide services under the Fee-Per-Item of Service
agreement are paid a fee for each Doctor/Patient contact.
STC - A Special Type Consultation fee is payable when a GMS eligible person is unable to contact their
registered Doctor and is seen as an emergency case by another. 
General Practitioners qualify for payment of ‘special fees’ for the special items of service separately
identified under the Capitation agreement and the Fee-Per-Item agreement.
Number of Claims in each Health Board 
Volume of Claims by Doctors
Fee-Per-Item 102,462
Special Type 186,460
Special Service 532,80
Out-of-Hours 547,00
National - Number of Claims - 2004 
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East Coast Area 55,929,652 21,193,960 9,843,161 53,728
South Western Area 89,309,160 37,792,221 15,032,459 54,948
Northern Area 84,686,262 33,427,386 13,106,413 100,731
Midland 51,766,261 12,729,283 5,078,340 88,624
Mid-Western 68,846,188 19,403,319 5,636,988 165,541
North Eastern 66,478,546 18,492,374 7,210,283 115,717
North Western 49,174,807 8,075,402 4,640,806 268,985
South Eastern 93,639,874 21,772,829 8,760,982 240,619
Southern 121,346,553 33,895,545 10,097,581 374,030
Western 82,140,770 17,176,575 6,144,056 328,604
National €763,318,073 €223,958,894 €85,551,069 €1,791,527
*EEA - Payment to Pharmacies to cover the cost of GMS prescriptions dispensed for residents from the European Economic Area.
Pharmacies were also paid in respect of the drugs/medicines dispensed under: Health (Amendment) Act 1996 - €1,362,789; Methadone Treatment Scheme -
€6,534,568; DTS Scheme - €520,046 and Patient Care Fees totalling €6,803,167 under the High Tech Drugs Scheme. (Payments to Wholesalers under the
High Tech Drugs Scheme amounted to €141,411,811).
In 2004,The National Maternity Hospital was paid €281,130 and The Rotunda Hospital was paid €1,758,196 in respect of Fertility Treatment. Under the
Drugs Payment Scheme Refunds eligible claiments were refunded €829,709.These figures are not included in the above table.
For details of Fees refer to page 34.
Health Board GMS DP LTI *EEA
€ € € €
Total of Payments to Pharmacies by Health Board
Corresponding 
figures for 2003 €650,662,243 €204,422,697 €73,348,251 €1,598,518
A GMS person who is provided with a properly completed GMS prescription form by his/her GP can
choose to have such prescription forms dispensed in any of the Pharmacies who have entered into
agreements with Health Boards for the provision of services under Section 59 of the Health Act, 1970.
In 2004 there were 12.8m prescription forms containing 35m prescription items dispensed at a cost of
over €747,905,845 i.e. an average cost of €21.35 per dispensed item. More than 96% of all eligible
GMS persons were prescribed for in the year. The average cost of medicines per GMS person in 2004
was €692.73.
Payments made to Pharmacies under the GMS and DTS Schemes are inclusive of the ingredient cost
of medicines, dispensing fees and VAT.
Under DP, LTI and EEA Schemes Pharmacies are reimbursed the ingredient cost of items dispensed;
dispensing fees and VAT; a markup of up to 50% on the ingredient cost of items dispensed is also paid.
The cost of the High Tech Drugs Scheme was €148.2m - at year end there were 28,385 persons
registered under this Scheme - Patient Care Fees totalled €6.8m and payments for drugs and medicines
totalled €141.41m.
In the year the Board processed claims valued at €279.77m on drugs acting on the ‘cardiovascular
system’ (GMS €178.90m, DP €85.25m and LTI €15.62m). The second highest cost category was
drugs acting on the ‘nervous system’ €216.17m (GMS €150.83m, DP €52.94m, LTI €12.40m). The
third highest amount paid was for drugs acting on the alimentary tract and metabolism system
€192.79m (GMS €114.93m, DP €53.86m, LTI €24m).
Payments to Pharmacies
GMS €763.32m DP €226.83m LTI €85.55m EEA €1.79m
General Medical Services Report 2004 21
Health Board GMS DP LTI EEA HTD *Other
Corresponding 
figures for 2003 32,240,507 9,311,284 1,463,793 75,737 143,195 227,900
East Coast Area 2,512,586 962,788 177,928 2,758 14,194 31,208
South West Area 4,183,805 1,546,975 289,084 2,670 23,918 103,757
Northern Area 3,799,519 1,415,475 266,366 4,452 20,587 79,387
Midland 2,343,854 593,852 99,921 3,743 11,273 7,429
Mid-Western 3,249,094 885,727 122,366 7,540 13,350 11,883
North Eastern 3,086,769 878,286 145,449 5,167 15,903 10,421
North Western 2,230,424 352,048 88,636 12,040 14,423 5,832
South Eastern 4,310,591 1,046,308 176,830 10,478 19,446 14,167
Southern 5,707,329 1,522,052 198,827 17,071 25,039 16,444
Western 3,606,282 729,123 109,300 14,611 19,804 11,097
National 35,030,253 9,932,634 1,674,707 80,530 177,937 291,625
* This group includes: 18,441 claim items in respect of the Health (Amendment) Act 1996; 200,254 items under the Methadone
Treatment Scheme and 72,930 prescription items under the DTS Scheme.
GMS - General Medical Services Scheme. DP - Drugs Payment Scheme.
LTI - Long Term Illness Scheme. EEA - European Economic Area. HTD - High Tech Drugs Scheme.
Other - Methadone Treatment Scheme, Health (Amendment) Act 1996 and Dental Treatment Services Scheme.
Volume of Claims by Pharmacies
EEA .08m
HTD .18m
Other .29m
LTI 1.67m
DP 9.93m
GMS 35.03m
National - Number of Items - 2004
GMS prescription forms processed for payment in the year totalled 12.8m - the total of prescribed items
was more than 35m - these accounted for approximately 74% of all items paid for by the Board in 2004.
Approximately 39.69% of GMS forms contained a single item; more than 20.60% contained 2 items -
the average number of items per form was 2.74 (2003 – 2.63).
GMS dispensed items paid for by the Board in 2004 increased by more than 2,789,746 - the increase in
the number of DP items was more than 621,350 - the overall increase in the number of pharmacy claims
processed by the Board in the year was more than 3.7m.
Number of Items in each Health Board
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Eastern Regional Boards €14,373,197
Midland € 2,726,168
Mid-Western € 4,455,816
North Eastern € 4,235,216
North Western € 3,384,872
South Eastern € 6,442,376
Southern € 9,454,969
Western € 7,360,214
National €52,432,828
Dentists were also paid a total of €55,587 in 2004 in respect of treatments under the Health (Amendment) Act 1996.
For details of Fees refer to page 35.
Dentists were paid a total of €52,432,828 in 2004, in respect of treatments provided for more than
237,828 GMS persons under the DTS Scheme.
The following treatments were available to all eligible GMS persons.
ROUTINE - Routine treatments are categorised as either ‘Above the Line’ or ‘Below the Line’:
‘Above the Line’ treatments are uncomplicated procedures viz. Amalgam; Extractions;
‘Below the Line’ treatments are advanced procedures viz. Protracted Periodontal;
Prosthetics.
‘Below the Line’ treatments - prior Health Board approval for a specific course of treatment under this
category is required. Full denture treatment is available, with prior Health Board approval, to all
edentulous GMS persons over 16 years. 
Health Board 2004
Payments to Dentists in each Health Board
Corresponding figure for 2003 €49,816,930
Payments to Dentists
Above the line €34.91m Below the line €17.52m
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Volume of Claims by Dentists
Above the Line  968,665
Below the Line 104,850
National - Volume of Treatments - 2004
Corresponding 
figures for 2003 960,342 109,119 229,812
Eastern Regional Boards 272,422 27,235 64,800
Midland 48,921 6,056 13,343
Mid-Western 81,391 9,992 21,270
North Eastern 78,974 9,343 20,304
North Western 69,847 5,016 17,041
South Eastern 112,106 15,048 27,831
Southern 182,181 17,535 44,605
Western 122,823 14,625 28,634
National 968,665 104,850 237,828
Health Board
+Below the
Line
+Above the
Line
No. of 
persons treated
under DTS
Volume of Treatments by Dentists in each Health Board
ROUTINE - Routine treatments are categorised as either ‘Above the Line’ or ‘Below the Line’:
‘Above the Line’ (ATL) treatments are uncomplicated procedures;
‘Below the Line’ (BTL) treatments are advanced procedures.
+ The most frequently used ATL service was Amalgam Restoration, which was used by 94,775 patients followed by Oral Examination.
In the BTL category the most frequently used service was Prosthetics followed by Radiographs and Protracted Periodontal.
Corresponding figure for 2003 €13,719,581
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Eastern Regional Boards €4,748,592
Midland €1,119,323
Mid-Western €1,553,275
North Eastern €1,169,098
North Western €1,156,687
South Eastern €2,396,421
Southern €2,427,537
Western €1,702,687
National 2004 €16,273,620
Opticians were also paid in respect of: Health (Amendment) Act 1996 €37,232; Optical services for Teenagers €85,280;
Optical services for Children €1,047,239.
For details of Fees refer to page 36.
Under the Health Board Community Ophthalmic Services Scheme, Optometric/Ophthalmic services are
provided to adult medical cardholders, which include free eye examinations and necessary spectacles/appliances.
Payments in respect of spectacles provided under the Children’s Scheme are also made by the Board on
behalf of the majority of Health Boards.
Payments in respect of eye examinations and necessary spectacles/appliances are provided under the
Teenager’s Scheme for eligible medical card holders on behalf of certain Health Boards.
In the 12-month period to the end of December 2004 claims were received on behalf of eligible persons
for 173,155 treatments costing €16,273,620. 
Eye examinations by Optometrists/Ophthalmologists totalled 165,526 - complete spectacles (distance,
reading and bi-focals) provided under the Scheme totalled 248,658. The balance of treatments included
replacement lenses and frames, tinted lenses, prisms and contact lenses. A breakdown of treatments and
payments by Health Board is shown hereunder.
Health Board 2004
Payments to Optometrists/Ophthalmologists in each Health Board
Payments to Optometrists/Ophthalmologists
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Volume of Treatments by Optometrists/
Ophthalmologists
Eye Exams 165,526
Appliances 248,658
National - Volume of Treatments - 2004
Eastern Regional Boards 48,578 70,400 118,978 50,278
Midland 10,218 16,090 26,308 11,095
Mid-Western 14,351 25,028 39,379 16,388
North Eastern 11,855 18,751 30,606 12,308
North Western 12,926 17,744 30,670 13,098
South Eastern 24,540 37,683 62,223 25,744
Southern 25,055 36,511 61,566 25,870
Western 18,003 26,451 44,454 18,374
National 165,526 248,658 414,184 173,155
Health Board Eye Exams Appliances Volume No. of
of Treatments Persons Treated
Volume of Treatments by Optometrists/Opthalmologists
in each Health Board
Corresponding 
figures for 2003 150,438 221,961 373,473 160,658
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Cost per Person
Health Board
GMS €954.26
DP €448.22
DTS €220.47
HBCOS €93.98
LTI €1,693.21
National – 2004
Cost per Person in each Health Board 
Eastern Boards 251.46 687.23 938.69 1,778.43 517.99 221.81 94.45
Midland 267.82 766.76 1,034.58 1,735.59 425.12 204.31 100.89
Mid-Western 254.57 702.08 956.65 1,396.33 416.56 209.49 94.78
North Eastern 272.06 705.20 977.26 1,651.84 397.93 208.59 94.99
North Western 244.23 583.17 827.40 1,690.64 438.19 198.63 88.31
South Eastern 264.59 704.59 969.18 1,674.50 413.41 231.48 93.09
Southern 275.04 724.12 999.16 1,656.70 396.58 211.97 93.84
Western 273.15 669.53 942.68 1,630.16 411.94 257.04 92.67
National €261.53 €692.73 €954.26 €1,693.21 €448.22 €220.47 €93.98
Corresponding 
figures for 2003 €247.66 €595.16 €842.82 €1,526.40 €430.90 €216.77 €85.40
The Doctor cost above does not include superannuation paid to retired DMOs.
The above table shows the actual cost per person in respect of those who availed of services under each
Scheme in 2004.
Medical and pharmaceutical services delivered to GMS persons increased in cost from €842.82 in 2003
to €954.26 in 2004 an increase of €111.44 per person - the cost of medical services per person
increased in cost from €247.66 in 2003 to €261.53 in 2004 an increase of 5.6% as did the cost per
person of pharmaceutical services €595.16 in 2003 to €692.73 in 2004 an increase of 16.4%.
GMS LTI DP DTS HBCOS
Net Cost Per Per 
Doctor Pharmacy Total Pharmacy Per Person Adult 
Cost Cost Cost Cost Claimant Treated Treated
€ € € € € € €
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Major Therapeutic Classification of Drugs, Medicines
and Appliances - General Medical Services Scheme
A Alimentary Tract and Metabolism 114.93 15.1
B Blood and Blood Forming Organs 32.98 4.3
C Cardiovascular System 178.90 23.4
D Dermatologicals 15.56 2.0
G Genito Urinary System and Sex Hormones 29.66 3.9
H Systemic Hormonal Preps. excl. Sex Hormones and Insulins 6.88 0.9
J Anti-infectives for Systemic Use 30.44 4.0
L Antineoplastic and Immunomodulating Agents 5.98 0.8
M Musculo-Skeletal System 55.75 7.3
N Nervous System 150.83 19.7
P Antiparasitic Products, Insecticides and Repellents 0.69 0.1
R Respiratory System 68.21 8.9
S Sensory Organs 14.29 1.9
V Clinical Nutritional Products 28.13 3.7
Diagnostic Products 12.96 1.7
Ostomy Appliances 8.50 1.1
Urinary Appliances 2.75 0.4
Needles/Syringes/Lancets 2.24 0.3
Dressings 1.42 0.2
Miscellaneous 2.22 0.3
Total €763.32m 100%
Major Therapeutic Classification €m %
N - 19.7%
A - 15.1%
R - 8.9%
V - 7.7%
C - 23.4%
Other - 25.2%
National – 2004
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Major Therapeutic Classification of Drugs, Medicines
and Appliances - Drugs Payment Scheme
Major Therapeutic Classification €m %
A - 15.3%
N - 15.1%
R - 11.7%
V - 3.6%
C - 24.3%
Other - 30.0%
National – 2004
Note: The above costs are inclusive of the monthly payment of €78 payable to the Pharmacy by the individual or family.
A Alimentary Tract and Metabolism 53.86 15.3
B Blood and Blood Forming Organs 10.70 3.1
C Cardiovascular System 85.25 24.3
D Dermatologicals 16.10 4.6
G Genito Urinary System and Sex Hormones 24.80 7.1
H Systemic Hormonal Preps. excl. Sex Hormones and Insulins 2.62 0.7
J Anti-infectives for Systemic Use 16.75 4.8
L Antineoplastic and Immunomodulating Agents 4.14 1.2
M Musculo-Skeletal System 25.72 7.3
N Nervous System 52.94 15.1
P Antiparasitic Products, Insecticides and Repellents 0.38 0.1
R Respiratory System 41.16 11.7
S Sensory Organs 3.74 1.1
V Clinical Nutritional Products 5.59 1.6
Ostomy Appliances 4.26 1.2
Urinary Appliances 1.16 0.3
Diagnostic Products 0.78 0.2
Dressings 0.42 0.1
Needles/Syringes/Lancets 0.16 0.0
Miscellaneous 0.61 0.2
Total €351.14m 100%
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Major Therapeutic Classification of Drugs, Medicines
and Appliances – Long Term Illness Scheme
Major Therapeutic Classification €m %
A - 28.0%
C - 18.3%
N - 14.5%
V - 32.1%
Other - 7.1%
National – 2004
A Alimentary Tract and Metabolism 24.00 28.0
B Blood and Blood Forming Organs 1.43 1.7
C Cardiovascular System 15.62 18.3
D Dermatologicals 0.13 0.1
G Genito Urinary System and Sex Hormones 0.74 0.9
H Systemic Hormonal Preps. excl. Sex Hormones and Insulins 0.65 0.8
J Anti-infectives for Systemic Use 1.82 2.1
L Antineoplastic and Immunomodulating Agents 0.08 0.1
M Musculo-Skeletal System 0.60 0.7
N Nervous System 12.40 14.5
P Antiparasitic Products, Insecticides and Repellents 0.00 0.0
R Respiratory System 0.48 0.5
S Sensory Organs 0.14 0.2
V Diagnostic Products 17.85 20.9
Clinical Nutritional Products 4.71 5.5
Needles/Syringes/Lancets/Swabs 3.01 3.5
Urinary Appliances 0.65 0.8
Nutritional/Ancillary Devices 0.56 0.6
Dressings 0.18 0.2
Ostomy Appliances 0.16 0.2
Miscellaneous 0.34 0.4
Total €85.55 100%
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Summary of Statistical Information relating to the 
GMS Scheme for each of the five years 2000-2004
Number of Eligible Persons
in December 1,148,914 1,158,143 1,168,745 1,199,454 1,148,055
Doctors (000’s) (000’s) (000’s) (000’s) (000’s)
Total Payments €306,250 €286,830 €271,939 €203,863 €165,975
Doctors’ Payment per Person €261.53 €247.66 €221.15 €169.46 €138.43
Pharmacies (000’s) (000’s) (000’s) (000’s) (000’s)
Total Cost of Prescriptions €747,905 €636,566 €537,874 €422,464 €328,348
Ingredient Cost €585,122 €503,578 €423,269 €329,497 €262,881
Dispensing Fee €149,081 €121,115 €104,827 €85,413 €59,325
VAT €13,702 €11,873 €9,778 €7,554 €6,142
Number of Forms 12,794 12,243 11,551 10,454 9,737
Number of Items 35,030 32,241 29,500 25,521 22,882
Cost per Form €58.46 €51.99 €46.57 €40.41 €33.72
Cost per Item €21.35 €19.74 €18.24 €16.55 €14.35
Ingredient Cost per Item €16.70 €15.62 €14.35 €12.91 €11.49
Items per Form 2.74 2.63 2.55 2.44 2.35
(000’s) (000’s) (000’s) (000’s) (000’s)
Total Cost of Stock Orders €15,413 €14,096 €13,018 €11,555 €10,455
Ingredient Cost €11,944 €10,904 €10,059 €8,945 €8,072
Pharmacy Fees €2,986 €2,726 €2,515 €2,222 €2,019
VAT €483 €466 €444 €388 €364
(000’s) (000’s) (000’s) (000’s) (000’s)
Overall Cost of Medicines €763,318 €650,662 €550,892 €434,019 €338,803
* Pharmacy Payment per Person €692.73 €595.16
Overall Payments €1,063,788 €937,493 €822,831 €637,882 €504,778
*Overall Payment per Person €954.26 €842.82
2004 2003 2002 2001 2000
Doctors’ payment per person is exclusive of superannuation paid to retired DMOs.
*Since 2003 these figures are based on the actual number of persons who availed of services.
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Summary of Statistical Information relating to the LTI and 
DP Schemes for each of the five years 2000-2004
LTI Scheme
Number of Eligible Persons in
December 93,504 97,184 92,745 87,988 82,619
*Number of Claimants 50,526 48,053
(000’s) (000’s) (000’s) (000’s) (000’s)
Number of Items 1,675 1,464 1,280 1,157 988
Total Cost €85,551 €73,348 €61,636 €52,081 €41,736
Cost per Item €51.08 €50.11 €48.15 €44.98 €42.26
*Cost per Claimant €1,693.21 €1,526.40
DP Scheme 
Number of Eligible Persons in
December 1,469,251 1,396,813 1,319,395 1,156,836 942,193
*Number of Claimants 499,664 474,411
(000’s) (000’s) (000’s) (000’s) (000’s)
Number of Items 9,933 9,311 9,063 8,985 7,776
Gross Cost €351,144 €315,832 €287,489 €262,187 €212,087
Net Cost €223,959 €204,422 €192,366 €177,617 €140,598
Gross Cost per Item €35.35 €33.92 €31.72 €29.18 €27.27
*Net Cost per Claimant €448.22 €430.90
2004 2003 2002 2001 2000
*Since 2003 these figures are based on the actual number of persons who availed of services under each Scheme.
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Fees and Allowances under Capitation Agreement
Ages Male Female Male Female Male Female Male Female Male Female
€ € € € € € € € € €
Up to 3 Miles 3-5 Miles 5-7 Miles 7-10 Miles Over 10 Miles
Up to 4 64.67 63.15 67.94 66.45 72.76 71.29 77.55 76.10 83.50 82.00
5 - 15 38.79 39.20 40.16 40.57 42.13 42.60 44.08 44.52 46.52 46.90
16 - 44 48.68 77.69 50.44 79.45 53.04 82.04 55.62 84.19 58.73 87.74
45 - 64 94.22 103.24 98.44 107.46 104.69 113.69 110.84 119.87 118.50 127.47
65 - 69 99.11 110.22 110.85 121.98 128.30 139.41 145.43 156.55 166.73 177.87
70 and over 108.74 120.18 120.83 132.32 138.87 150.31 156.56 168.04 178.54 190.05
Out-of-Hours Payment
Surgery €37.31
Domiciliary
Up to 3 miles €37.31
3 - 5 miles €49.78
5 - 7 miles €56.06
7 - 10 miles €62.20
Over 10 miles €74.66
Additional Fee €29.14
*Special Items of Service
(i) to (ix) €23.33
(x) and (xi) €35.01
(xii) €58.36
(xiii) €40.49
(xiv) €64.74
(xv) and (xvi) €32.12
(xvii) €48.17
(xviii) €115.81
+Mileage
Temporary Residents
Surgery €37.31
Domiciliary
Up to 3 miles €37.31
3 - 5 miles €49.78
5 - 7 miles €56.06
7 - 10 miles €62.20
Over 10 miles €74.66
Rural Dispensing Fee €11.35
Fee for Second Medical Opinion €24.89
Practice Payments for Rural Areas
Rural Practice Allowance Per Annum €15,313.74
Practice Support
Allowance for Practice Secretary
up to a maximum Per Annum of €20,491.10
Allowance for Practice Nurse
up to a maximum Per Annum of €32,200.30
Contributions to Locum Expenses
(Subject to the conditions of the Agreement)
Annual Leave Up to a maximum of 
Sick Leave €1,299.02 per week
Study Leave Up to a maximum of 
Maternity Leave
€185.57 per day
Paternity Leave
Contributions to 
Medical Indemnity Insurance
Calculation of contribution is related to GMS
panel numbers and net premium.
Asylum Seekers
A one off superannuable registration fee of
€143.50 per relevant patient will be paid to
Doctors in respect of each such patient on 
their GMS Scheme panels.
Capitation Fees as at 31st December 2004
* Special Items of Service.
(i) Excisions/Cryotherapy/
Diathermy of Skin Lesions.
(ii) Suturing of Cuts and
Lacerations.
(iii) Draining of Hydroceles.
(iv) Treatment and Plugging 
of Dental and Nasal
Haemorrhages.
(v) Recognised Vein Treatment.
(vi) ECG Tests and their
Interpretation.
(vii) Instruction in the fitting
of a Diaphragm.
(viii) Removal of Adherent
Foreign Bodies from the
Conjunctival Surface of
the Eye.
(ix) Removal of Lodged or
Impacted Foreign Bodies
from the Ear, Nose and
Throat.
(x) Nebuliser Treatment 
in the case of Acute
Asthmatic Attack.
(xi) Bladder Catheterization.
(xii) Attendance at case
conferences (in cases
where such are convened
by a DCC/MOH).
(xiii) Advice and Fitting 
of a Diaphragm.
(xiv) Counselling and 
Fitting of an IUCD.
(xv) Pneumococcal Vaccination.
(xvi) Influenza Vaccination.
(xvii) Pneumococcal/Influenza
Vaccination.
(xviii) Hepatitis B Vaccination.
Above rates inclusive of supplementary Out-of-Hours Fee.
The Capitation rate is €495.07 per annum for persons aged 70 years and over in the community issued
with a medical card for the first time regardless of income. A Capitation rate of €717.48 per annum will
apply to anyone aged 70 years and over in a private nursing home (approved by a Health Board) for
continuous periods in excess of five weeks.
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Fees and Allowances under the Fee-Per-Item Agreement and
Fees under the Immunisation Scheme, Health (Amendment)
Act 1996 and Methadone Treatment Scheme
As at
Surgery Consultations 31st December 2004
Day Normal Hours €10.28
Late Outside Normal Hours other than (Night) €14.61
Night Midnight to 8.00 a.m. €28.91
Domiciliary Consultations
Day Normal Hours
Urban €15.17
Up to 3 miles €15.17
3-5 miles €19.86
5-7 miles €26.66
7-10 miles €33.43
Over 10 miles €41.81
Late Outside Normal Hours
Urban €19.86
Up to 3 miles €19.86
3-5 miles €25.67
5-7 miles €33.43
7-10 miles €44.41
Over 10 miles €52.09
Night Midnight to 8.00 a.m.
Urban €38.93
Up to 3 miles €38.93
3-5 miles €50.03
5-7 miles €63.29
7-10 miles €70.63
Over 10 miles €76.68
Emergency Fee/EEA Fee (Additional to Standard Fee) €11.24
Dispensing Fee €11.24
Rural Practitioner’s Allowance
Per Annum €6,626.58
Locum and Practice Expense Allowance
Per Annum €1,290.02
Sessional Rate - Homes for the Aged
Per 3 Hour Session €68.85
*Special Items of Service
(i) to (vii) €21.11
(viii) and (ix) €32.12
(x) €48.17
(xi) €115.81
Immunisation Fees
(i) Registration of child with a GP €33.68
(ii) Complete course of immunisation against
DPT/DT; Hib; Polio and MMR €112.21
(iii) 95% uptake bonus €54.05
Health (Amendment) Act 1996
Surgery Fee €32.16
Domiciliary Fee €42.40
Methadone Treatment Scheme
Level 1 Contractor €131.91
Level 2 Contractor €145.49
* Special Items of Service.
(i) Excisions/Cryotherapy/
Diathermy of Skin
Lesions.
(ii) Suturing of Cuts and
Lacerations.
(iii) Draining of Hydroceles.
(iv) Treatment and Plugging
of Dental and Nasal
Haemorrhages.
(v) Recognised Vein
Treatment.
(vi) ECG Tests and their
Interpretation.
(vii) Instruction in the fitting
of a Diaphragm.
(viii) Pneumococcal
Vaccination.
(ix) Influenza Vaccination.
(x) Pneumococcal/Influenza
Vaccination.
(xi) Hepatitis B Vaccination.
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Scale of Fees Payable to Participating Pharmacists 
as at 31st December 2004
High Tech Medicines Scheme
Reimbursement of ingredient cost plus
50% mark-up on ingredient cost plus
Standard Fee - 259c (Note 1)
20% mark-up on Incontinence Products and Dressings under DP Scheme
Extemporaneously dispensed preparations are reimbursed at current private prescription rates.
In the case of the Drugs Payment Scheme the Board makes payments to Pharmacies in respect of
authorised Patients whose monthly costs of prescribed drugs and medicines are in excess of the
specified monthly amount (currently €78) payable to the Pharmacy by an individual or family.
Note 1 The standard fee is an all inclusive fee which includes container and broken bulk allowance.
Patient Care Fee: €49.64 per month.
Methadone Treatment Scheme 
Patient Care Fee: Up to a Maximum of €49.59 per month.
DP/LTI/EEA Schemes and Health (Amendment) Act 1996
GMS Scheme c
Standard Fee-Per-Item (Note 1) 298.00
Extemporaneous Fee 570.02
Extemporaneous dispensing and compounding of
- Powders 1,710.05
- Ointments and Creams 1,140.03
Controlled Drugs 460.18
Non-Dispensing - exercise of professional judgement 285.01
Phased Dispensing - each part of phased dispensing 285.01
Urgent/Late Dispensing
Additional fee for Urgent/Late dispensing other than between
midnight and 8.00 a.m. (Note 2) 793.62
Additional fee for Urgent/Late dispensing 
between midnight and 8.00 a.m. 1,639.14
Note 1 253.71c basic fee and 44.28c allowance for containers, obsolescence etc.
Note 2 Urgent fee prescriptions are those so specified by the prescriber and necessarily 
dispensed outside normal hours.
Late fee prescriptions are those which, though not marked urgent, are in 
exceptional circumstances necessarily dispensed outside normal hours by the 
Pharmacist, having regard to the person’s requirements.
Note 3 A Standard Fee-Per-Item is also payable on prescription forms issued by Dentists under the DTS Scheme.
Note 4 A Fee-Per-Item of 392.71c is also payable on prescription forms in respect of persons aged 70 years 
and over issued with a medical card for the first time regardless of income.
Supplies to Dispensing Doctors
Pharmacies supplying Dispensing Doctors are reimbursed on the basis of the basic trade price 
with the addition of 25% on cost.
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Scale of Fees Payable under the 
Dental Treatment Services Scheme
Oral Examination 28.90
Prophylaxis 27.15
Restoration (Amalgam) 43.68
Restoration (Composite) 6 anterior teeth only 45.28 
Exodontics (Extraction under local anaesthetic) 34.51
Surgical Extraction - Maximum 3 units:
Fee payable for each 15 minute unit 30.73
Maximum 92.19
1st Stage Endodontic Treatment (Anterior teeth only) 50.00
Denture Repairs
1st Item of Repair 39.76
Each Subsequent Item 12.74
Maximum 65.25
Apicectomy/Amputation of Roots *Dentist 
Estimate
Endodontics (Anterior teeth only) *Dentist 
Estimate
Protracted Periodontal Treatment *Dentist 
Estimate
Radiographs
1 Film 21.62
2 or more Films 32.69
Panoramic 36.19
Miscellaneous
(e.g. Abcess, Haemorrhage, Dressings etc.) 19.77
Prosthetics
Full Upper or Lower Denture 271.01
(Other than Edentulous Persons)
Partial Upper or Lower Acrylic Denture 198.78
Complete Upper or Lower Reline 108.49
Complete Upper and Lower Reline 180.59
Full Upper and Lower Denture (Edentulous Persons Only) 397.72
As at 
31st December 2004
Treatment Type Routine
€
* Dentist Estimates are subject to agreement between a Dentist and a Health Board.
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Scale of Fees Payable under the Health Board Community
Ophthalmic Services Scheme
Eye Examination Ophthalmic Optician 21.11
Eye Examination Ophthalmologist/
Ophthalmic Medical Practitioner 23.95
Medical Eye Examination by Ophthalmologist 47.90
Eye Examination for Contact Lenses (Grant) 66.27 (H)
Appliances
Single Vision Complete Appliances
Spectacles - Distance 44.43
Spectacles - Reading 44.43
Spectacles - Uncollected 31.36
Contact Lenses 35.36
Contact Lenses Standard 
or Disposable per pair (Grant) 69.14 (H)
Single Vision Spectacles - 
with Glass Lenses Distance 119.11 (H)
Single Vision Spectacles - 
with Glass Lenses Reading 119.11 (H)
Single Vision Spectacles - 
with Plastic Lenses Distance 131.64 (H)
Single Vision Spectacles - 
with Plastic Lenses Reading 131.64 (H)
Single Vision Lenses to Own Frame
Replacement Distance Lens (1) 
to own frame 17.27
Replacement Distance Lenses (2) 
to own frame 34.54
Replacement Reading Lens (1) 
to own frame 17.27
Replacement Reading Lenses (2) 
to own frame 34.54
Single Vision Lenses to Non-Standard Frame
Single Vision Lens (1) (Glass) Distance 25.39 (H)
Single Vision Lenses (2) (Glass) Distance 50.78 (H)
Single Vision Lens (1) (Glass) Reading 25.39 (H)
Single Vision Lenses (2) (Glass) Reading 50.78 (H)
Single Vision Lens (1) (Plastic) Distance 28.71 (H)
Single Vision Lenses (2) (Plastic) Distance 57.42 (H)
Single Vision Lens (1) (Plastic) Reading 28.71 (H)
Single Vision Lenses (2) (Plastic) Reading 57.42 (H)
Additional Specification for Lenses to All
Spectacle Types
Additional Specification for Lens (1)
to all Spectacles (Grant) 84.24 (H)
Additional Specification for Lenses (2)
to all Spectacles (Grant) 168.48 (H)
Other Items - Single Vision
Lenticular Lens (1 Surface) 11.92
Lenticular Lenses (2 Surfaces) 23.84
Lenticular Lenses (3 Surfaces) 35.76
Lenticular Lenses (4 Surfaces) 47.67
Tinted Lens (1) 7.79
Tinted Lenses (2) 15.57
Tinted Lenses (3) 23.36
Tinted Lenses (4) 31.15
Prism (1) 6.45
Prisms (2) 12.90
Prisms (3) 19.35
Prisms (4) 25.80
Prisms (5) 32.25
Prisms (6) 38.70
Prisms (7) 45.15
Prisms (8) 51.59
Dioptric powers higher than 8.00 (1) Lens 6.15
Dioptric powers higher than 8.00 (2) Lenses 12.29
Dioptric powers higher than 8.00 (3) Lenses 18.44
Dioptric powers higher than 8.00 (4) Lenses 24.59
Anti-Reflective Coating on Plastic Lens (1) 18.54 (H)
Anti-Reflective Coating on Plastic Lenses (2) 37.07 (H)
Dioptric powers higher than 6.00 
(Plastic) (1) Lens 15.37
Dioptric powers higher than 6.00 
(Plastic) (2) Lenses 30.73
Dioptric powers higher than 6.00 
(Plastic) (3) Lenses 46.10
Dioptric powers higher than 6.00 
(Plastic) (4) Lenses 61.47
Plastic Lens (1) for Children as prescribed 4.90
Plastic Lenses (2) for Children as prescribed 9.80
Plastic Lens (1) Adult 4.90 (H)
Plastic Lenses (2) Adult 9.80 (H)
Bifocals
Spectacles Bifocal Complete 89.37
Fused Bifocal Spectacles 170.63 (H)
Varifocal Spectacles - Glass or Plastic 266.38 (H)
Bifocal Lenses
Replacement Bifocal Lens (1) to own frame 39.77
Replacement Bifocal Lenses (2) 
to own frame 79.54
Bifocal Lens (1) to Non-Standard Frame 52.31 (H)
Bifocal Lenses (2) to Non-Standard Frame 104.62 (H)
Varifocal Lens (1) (Grant) 99.97 (H)
Varifocal Lenses (2) (Grant) 199.94 (H)
Other Items - Bifocals
Sphere over 6.00 and up to 9.00 
extra charge (1) Lens 4.15
Sphere over 6.00 and up to 9.00 
extra charge (2) Lenses 8.30
Sphere over 9.00 extra charge (1) Lens 9.22
Sphere over 9.00 extra charge (2) Lenses 18.44
Tinted Lens (1) 8.55
Tinted Lenses (2) 17.11
Prism (1) 9.09
Prisms (2) 18.17
Repairs
Replacement Frame to own lenses 13.52
Replacement Front to own lenses 6.22
Replacement Side (1) to own frame 2.61
Replacement Sides (2) to own frame 5.23
Complete New Frames 90.00 (H)
Examinations € €
As at 31st December 2004
(H) Denotes fees payable in respect of services under the Health
(Amendment) Act 1996 only.
Financia l
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The Board is required by the General Medical Services (Payments) Board (Establishment) Order, 1972
to prepare financial statements for each financial year which give a true and fair view of the state of the
affairs of the General Medical Services (Payments) Board and of the income and expenditure for that
period.
In preparing those statements, the Board is required to –
● select suitable accounting policies and apply them consistently 
● make judgements and estimates that are reasonable and prudent
● disclose and explain any material departures from applicable accounting standards
● prepare the financial statements on a going concern basis unless it is inappropriate to presume
that the General Medical Services (Payments) Board will continue in existence.
The Board is responsible for keeping proper accounting records which disclose with reasonable
accuracy at any time the financial position of the General Medical Services (Payments) Board and which
enable it to ensure that the financial statements comply with the Order. It is also responsible for
safeguarding the assets of the General Medical Services (Payments) Board and hence for taking
reasonable steps for the prevention and detection of fraud and other irregularities.
On behalf of the Board
Maureen Windle, Chairman
Seamus Mannion, Vice Chairman
Statement of Board Members’ Responsibilities
for year ended 31st December 2004
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Responsibility for the System of Internal
Financial Controls
On behalf of the Board of the General Medical
Services (Payments) Board I acknowledge our
responsibility for reviewing and ensuring the
effectiveness of the organisations system of
internal financial controls.
The Management of the Board through the Chief
Officer is responsible for monitoring the system
of internal control and providing assurances to
the Board.
A system of internal control is designed to reduce
rather than eliminate risk and such a system can
provide only a reasonable and not an absolute
assurance that assets are safeguarded, transactions
authorised and properly recorded, and that
material errors or irregularities are either
prevented or would be detected in a timely
manner.
Key Control Procedures
The following is a description of the key
procedures which have been put in place by our
Board designed to provide effective internal
financial control.
(i) The Board has an established organisational
structure with clearly defined lines of
responsibility and reporting. The Board's
Executive has responsibility for the
implementation and maintenance of the system
of internal financial control. Formal procedures
for reporting significant control failures and
ensuring corrective action are in place.
(ii) The strength of the internal financial control
systems is dependant on the quality and
integrity of both management and staff.
(iii) The Board operates a comprehensive
Financial Management and Reporting
process. The Board's expenditure is
monitored against allocation on a monthly
basis by the Department of Health &
Children with all significant variances
investigated and explained.
(iv) The Board has defined authorisation
procedures in respect of procurement and
payment of creditors. These authorisation
limits together with statements on internal
control requirements are set out in the
Board's Financial Regulations.
(v) The procedures for monitoring the
effectiveness of the internal financial control
system include:
● A Finance Committee which meets
regularly and reviews financial
performance;
● The Board's Financial Management
System contains inbuilt authorisation
controls to ensure that only authorised
staff can carry out the specific processes;
● The work of Internal Audit which is
informed by analysis of the risk. The
Internal Audit plans are endorsed by the
Audit Committee;
● An Audit Committee which meets at least
quarterly and which includes independent
non-executive members.
(vi) The Board's monitoring and review of the
effectiveness of the system of internal control
is informed by the work of the members of
the Board, the Finance & Audit Committees,
the Internal Auditor and the comments made
by the Comptroller and Auditor General in
his management letter or other reports.
Review of Controls
I confirm that in the year ended 31st December
2004 the Board carried out a review of internal
financial controls.
On behalf of the Board
Maureen Windle, Chairman
Statement on the System of Internal Financial Control
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The Board was set up to make payments on behalf of
the Health Boards for general practitioner,
pharmaceutical services, dental treatment and
ophthalmic services, which the Health Boards
provide to qualifying persons under the Health Act
1970. The Board is reimbursed its direct costs
together with the administration costs incurred in
operating the payments service as set out in Note 1 to
the Financial Statements.
1. Basis of Accounting
The accounts have been prepared on an accruals basis
to reflect the costs of medicines and medical services
provided, and the administration costs incurred in the
year, and the matching income receivable to fund
these costs.
By direction of the Minister for Health & Children
no provision has been made in respect of benefits
payable under the Local Government
Superannuation Scheme.
2. Doctors’ Fees and Allowances
Most services from Doctors are provided under an
agreement concluded in 1989. Fees are mainly based
on capitation taking into account the age of the
patient and the distance from the surgery. 
3. Pharmaceutical Services
Payments to Pharmacists are made under a service
agreement with Health Boards concluded in 1996.
This agreement covers medical card holders and
other schemes. With effect from 1996 claims have
been subject to third party confirmation.
4. Dental Treatment Services Scheme
Payments under this heading comprise amounts paid
to Dentists operating as private practitioners in
respect of dental treatment provided for GMS
patients. The balance of such treatment is provided
directly by the Health Boards.
5. Health Board Community Ophthalmic 
Services Scheme
Payments under this heading comprise amounts paid
from 1st July 1999 to Optometrists and
Ophthalmologists operating as private practitioners
in respect of examinations and appliances provided to
adult GMS patients. Services for children are
separately provided for by Health Boards.
6. Fixed Assets and Depreciation
Fixed Assets are stated at cost less accumulated
depreciation. Depreciation is provided for on all fixed
assets in order to write off the cost or valuation of the
assets over their anticipated useful lives. The
following rates of Depreciation have been applied on
a straight line basis.
Furniture, Fixtures & Fittings 10%
Information Technology 20%
Library 10%
Office Equipment 10%
7. Superannuation
Staff
No provision has been made in respect of benefits
payable under the Local Government
Superannuation Scheme as the liability is
underwritten by the Minister for Health & Children.
Contributions from employees who are members of
the Scheme are credited to the Income and
Expenditure Account when received. Pension
payments under the Scheme are charged to the
Income and Expenditure Account when paid.
Doctors
A contribution of 10% of capitation payments is made
by the Board towards the superannuation of
participating Doctors.
8. Income
In accordance with the Board's Establishment Order,
payments made by the Board in respect of services,
along with its other expenses, are met by the Health
Boards and by the Department of Health & Children
on behalf of Health Boards. On this basis the Board
recognises income to match expenditure as it is
incurred. Since 1987 the practice has been each year
that the core allocation to the Board, for the Medical
Card Scheme, has been provided through the
Department of Health & Children vote.
9. Stocks
Dispensing Doctors’ Stocks
Medicines, drugs and appliances can only be supplied
to a Dispensing Doctor on receipt of a stock order
form fully completed by him/her that has received
approval from the Health Board.
High Tech Stocks
Under the arrangements in place for the supply of
High Tech Medicines by Community Pharmacies,
supply of drugs/medicines can be called forward from
Wholesalers by Community Pharmacists for
dispensing to approved persons.
Accounting Policies
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2004 2003
Notes € €
Income
Recoupment from Department of Health &
Children and Health Boards 1 1,636,175,016 1,463,637,814 
Rebate from Pharmaceutical Manufacturers 15,941,503 14,788,005
Other Income 2 1,923,284 532,457
Total Income 1,654,039,803 1,478,958,276
Expenditure
Administration 3 15,495,193 12,495,917
Doctors’ Fees and Allowances 4 323,624,764 311,689,130
Pensions paid to former DMOs or Dependants 5 5,817,788 5,907,892
Pharmaceutical Services 6 1,234,067,301 1,080,347,266
Dental Treatment Services Scheme 7 53,351,168 50,126,119
Community Ophthalmic Services Scheme 8 17,472,605 14,818,079
Depreciation 10 912,111 924,748
Total Expenditure 1,650,740,930 1,476,309,151
Surplus/(Deficit) for year 3,298,873 2,649,125
Accumulated fund at 1st January 12,224,027 9,574,902
Accumulated fund at 31st December 15,522,900 12,224,027
A statement of recognised gains and losses has not been prepared as the only recognised surplus for the year
and the preceeding year was the surplus as stated above.
The Accounting Policies and Notes 1-16 form part of these Financial Statements.
Income and Expenditure Account
for year ended 31st December 2004
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2004 2003
Notes € € € €
Fixed Assets 10 1,388,930 2,080,585
Current Assets
Debtors 11 248,805,390 235,335,690
Stocks on Hand 12 14,108,903 10,118,375
Bank 1,036,144 5,685,934
Cash 201 152
263,950,638 251,140,151
Current Liabilities
Creditors 13 249,816,668 240,996,709
249,816,668 240,996,709
Net Current Assets 14,133,970 10,143,442
Net Assets 15,522,900 12,224,027
Represented by:
Accumulated Fund 15,522,900 12,224,027
The Accounting Policies and Notes 1-16 form part of these Financial Statements.
Balance Sheet as at 31st December 2004
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2004 2003
Note € €
Net Cash (Outflow)/Inflow
from Operating Activities (A) (4,429,285) 10,260,418
Investing Activities
Purchase of Fixed Assets (220,456) (940,627)
(Decrease)/Increase in Cash
and Cash Equivalents (B) (4,649,741) 9,319,791
(A) Analysis of Net Cash Inflow/(Outflow) from Operating Activities
2004 2003
€ €
Operating Surplus/(Deficit) 3,298,873 2,649,125
Depreciation Charges 912,111 924,748
(Increase)/Decrease in Debtors (13,469,700) (44,662,155)
(Increase)/Decrease in Stocks on Hand (3,990,528) (2,633,246)
Increase/(Decrease) in Creditors 8,819,959 53,981,946
Net Cash (Outflow)/Inflow
from Operating Activities (4,429,285) 10,260,418
(B) Reconciliation of Increase/(Decrease) in cash and cash equivalents
as shown in the Balance Sheet
2004 2003 Change
€ € in Year
Bank 1,036,144 5,685,934 (4,649,790)
Cash in Hand 201 152 49
1,036,345 5,686,086 (4,649,741)
Cash Flow Statement for year ended 
31st December 2004
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1. Recoupment from Department of Health & Children/Health Boards
The Health Boards fund the cost of the following Schemes administered by the Board - Drugs
Payment Scheme/Long Term Illness Scheme/Ophthalmic Services Scheme/Dental Treatment Services
Scheme/Childhood and GMS Immunisation Schemes/High Tech Drugs Scheme in respect of 
Non-GMS patients and Methadone Scheme. Funding for the other schemes and services
administered by the Board, as well as the Board’s administration costs, is provided by the
Department of Health & Children, on behalf of the Health Boards.The sums provided were:
2004 2003
€ €
Department of Health & Children 1,176,017,205 1,050,277,557
Health Boards 460,157,811 413,360,257
1,636,175,016 1,463,637,814
2. Other Income
2004 2003
€ €
Superannuation deductions GMS Staff 233,235 201,247
Superannuation deductions former District Medical
Officers and Dependants 35,053 33,007
Bank Interest and Sundries 1,654,996 298,203
1,923,284 532,457
3. Administration Expenditure
2004 2003
€ €
Staff Remuneration 5,367,861 4,878,681
Health Board Stationery 1,221,950 1,157,941
Computer Development 2,724,498 3,358,638
Premises Rent and Services 522,995 377,110
Office Supplies, Printing and Stationery 1,643,087 1,410,727
Bank Interest/Charges 10,461 14,769
Repairs and Maintenance (Equipment & Premises) 115,037 117,260
Postage and Telephone 1,016,533 576,269
Journals and Periodicals 117,042 108,421
Medical Training Courses - -
Legal Expenses 4,612 15,691
Audit Fee 79,500 49,434
Bad Debts/Bad Debts Provision - -
Sundry Administration 2,671,617 430,976
15,495,193 12,495,917
Notes to the Financial Statements
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4. Doctors’ Fees & Allowances 2004 2003
€ €
Fees
Capitation 156,471,183 154,276,815
Board's contribution to Doctors’ Superannuation Scheme 16,111,805 15,205,570
Special Type Consultations/Special Services 23,252,232 21,677,260
Out-of-Hours Fees 25,073,213 22,464,250
Fee-Per-Item Services 1,226,438 1,374,424
Dispensing Fees 1,854,761 2,393,349
Registration/Vaccination Fees 4,026,347 4,083,044
Methadone Fees 5,448,634 2,497,034
Heartwatch 1,500,387 1,022,800
Other Payments 217,531 201,587
235,182,531 225,196,133
Allowances
Leave (Annual/Sick/Study/Maternity/Paternity) 10,243,005 9,361,006
Rural Practice Allowance 3,027,274 2,966,901
Practice Support 42,786,700 36,895,398
Rostering/Out-of-Hours Payments 6,590,173 6,535,443
Practice Equipment Payment 4,288,672 4,356,914
Locum & Practice Expenses 6,416 63,433
Medical Indemnity Insurance 2,167,783 1,772,892
Practice Support Grant 2,651,607 2,523,658
Drug Target Refunds 13,037,893 18,706,749
IMO Agreement:
Trainers/Trainees/One in One Rotas 1,656,627 1,457,736
86,456,150 84,640,130
Salaries
Salaries and Lump Sums to District Medical Officers 1,986,083 1,852,867
Total Doctors’ Fees & Allowances 323,624,764 311,689,130
5. Payments to Former District Medical Officers/Dependants
The Board made superannuation payments to 259 former District Medical Officers or their
dependants. These payments arose from the officer status with Health Boards of the Doctors and
their entitlement to hold General Practitioner contracts.
6. Pharmaceutical Services 2004 2003
€ €
Pharmacists’ GMS Claims 762,331,686 676,452,624
DP/LTI Claims 317,198,147 288,282,181
European Economic Area Claims 1,837,458 1,661,883
High Tech Claims 144,797,406 106,818,906
Other Payments 1,368,036 1,147,623
Methadone Treatment Claims 6,534,568 5,984,049
1,234,067,301 1,080,347,266
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7. Dental Treatment Services Scheme
2004 2003
€ €
Emergency - -
Routine Dental Treatments 53,322,236 50,069,464
Denture Claims (5,463) 27,675
Laboratory Claims - -
Other Payments 34,395 28,980
53,351,168 50,126,119
8. Community Ophthalmic Services Scheme
Fees 9,393,141 7,675,257
Appliances 8,079,464 7,142,822
17,472,605 14,818,079
9. Leasehold Premises
The Board's office premises are held on a 35 year lease dated 1st December 1974 from Calvinia Ltd.
The annual rent is €177,763, effective from 1st December 1999, with 5 year rent reviews.The
matter of securing a valuation of the Board's leasehold interest, with a view to its inclusion in the
Balance Sheet was examined. In the absence of any quantifiable benefit to the Board the cost of a
valuation could not be justified at this time.
10. Fixed Assets
Furniture Information Library Office Total
Fixtures Technology Equipment
Fittings
Cost € € € € €
Cost at 1.1.04 658,272 6,500,379 2,223 151,160 7,312,034
Additions 2004 14,180 200,098 75 6,103 220,456
672,452 6,700,477 2,298 157,263 7,532,490
Depreciation
Accumulated Depreciation 
at 1.1.04 594,796 4,568,813 2,000 65,840 5,231,449
Depreciation for Year 
ended 31.12.04 12,366 883,898 121 15,726 912,111
607,162 5,452,711 2,121 81,566 6,143,560
Net Book Value at 31.12.04 65,290 1,247,766 177 75,697 1,388,930
Net Book Value at 31.12.03 63,476 1,931,566 223 85,320 2,080,585
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11. Debtors
2004 2003
€ €
Department of Health & Children and Health Boards 225,560,598 208,396,478
Rebates due from Pharmaceutical Manufacturers 6,663,347 6,789,780
Advance Payments to Pharmacists 16,487,668 18,355,725
Sundry Debtors 93,777 1,793,707
248,805,390 235,335,690
12. Stocks on Hand
Dispensing Doctors’ Stocks 2,179,314 2,103,550
High Tech Stocks 11,929,589 8,014,825
14,108,903 10,118,375
13. Creditors
Doctors’ Fees/Salaries 74,428,052 78,003,729
Pharmacists’ Claims 163,296,883 151,539,856
Dental Treatment Services Scheme 5,989,556 6,381,016
Community Ophthalmic Services Scheme 1,534,703 1,376,418
Sundry Creditors 4,567,474 3,695,690
249,816,668 240,996,709
14. Indicative Drug Target Scheme - Cumulative Savings
The following table gives a breakdown of the cumulative savings made and the amounts paid under
the Indicative Drug Target Savings Scheme.
Savings Generated General
Health Board Practitioner Total
€ € €
Eastern Regional Boards 6,488,090 38,494,097 44,982,187
Midland 1,325,822 6,413,874 7,739,696
Mid-Western 1,872,330 9,970,997 11,843,327
North Eastern 1,961,325 10,255,251 12,216,576
North Western 2,768,197 17,284,645 20,052,842
South Eastern 3,310,145 16,142,989 19,453,134
Southern 3,351,610 17,870,926 21,222,536
Western 3,794,825 20,969,779 24,764,604
Research & Education Fund - - 2,830,074
National Savings 24,872,344 137,402,558 165,104,976
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14. Indicative Drug Target Scheme - Cumulative Savings (continued)
The following table gives a breakdown of the cumulative savings made and the amounts paid under
the Indicative Drug Target Savings Scheme.
Payments General
Health Board Practitioner Total
€ € €
Eastern Regional Boards 4,224,577 22,713,418 26,937,995
Midland 1,245,645 4,045,810 5,291,455
Mid-Western 1,813,527 6,903,376 8,716,903
North Eastern 1,401,439 7,226,083 8,627,522
North Western 2,173,859 14,422,490 16,596,349
South Eastern 2,731,367 11,948,796 14,680,163
Southern 2,325,061 13,379,068 15,704,129
Western 2,148,396 12,971,760 15,120,156
Research & Education Fund - - 1,899,220
National Savings Distributed 18,063,871 93,610,801 113,573,892
Balance of Savings at 
31st December 2004 6,808,473 43,791,757 51,531,084
15. Invalid/Ineligible Claims
Following a Government Decision in December 2002, the Minister for Health & Children directed
that the practice of reimbursing Community Pharmacy Contractors for claims in cases where the
eligibility of the patient cannot be verified be discontinued.The Board has taken the necessary steps
to implement this decision.
16. GMS Medical Cards Disclosure in Respect of Persons Aged 70 years and Over
A national review of the GMS panels in respect of persons aged 70 or over commenced in April
2002 to determine the level of excess payments to GPs in respect of ineligible patients and duplicate
records. Management and Control of the Register has been strengthened and a significant body of
work has been completed in relation to this matter. The Department of Health & Children, the
Health Boards and the Board are committed to the recovery of any excess payments, taking account
of the legal and practical issues involved.



